-+ 0.00%
-+ 0.00%
-+ 0.00%

Bernstein Maintains Market Perform on Biogen, Raises Price Target to $157

Benzinga·11/03/2025 12:49:03
Listen to the news
Bernstein analyst William Pickering maintains Biogen (NASDAQ:BIIB) with a Market Perform and raises the price target from $155 to $157.